
Sherwin-Williams
SHW · NYSE · Chemicals
Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time
- Market cap
- $85,2 bn
- Div. yield
- 0,9%
- Year to date
- +8,0%
Ratio score
based on 8 metrics as of 16.11.2026 ·
Verdict by our methodology based on current metrics. Not an investment recommendation.
Key metrics
4 ✓ · 4 — · 0 ✕ · 2 n/a · hover over a row or tap it to see the trend
All metrics
| Metric | Value | 5-year median | Industry median |
|---|---|---|---|
| P/E TTM | 31,6 | 31,8 | 31,6 |
| Forward P/E | 25,5 | — | 17,7 |
| PEG | 3,3 | — | 3,3 |
| P/S | 3,4 | 3,4 | 2,2 |
| EV/EBITDA | 24,7 | 25,4 | 22,4 |
| P/FCF | 27,5 | — | 27,5 |
| P/B | 21,3 | 20,2 | 3,2 |
Industry median — across 9 profitable companies in “Chemicals” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.
Price chart
Compare with
Choose a stock
Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.
Analysts
Ratings, 34 analysts
- Buy
- 18
- Hold
- 16
- Sell
- 0
Beat the EPS forecast in 3 of the last 4 quarters
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Q3 2026 | 3,72 | 3,63 | Down −2,5% |
| Q2 2026 | 3,55 | 3,70 | Up +4,1% |
| Q1 2026 | 2,28 | 2,35 | Up +3,1% |
| Q4 2025 | 2,18 | 2,23 | Up +2,1% |
Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.
Financials in charts
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6,86 bn | 6,79 bn | 5,67 bn | 5,60 bn | 6,36 bn | 6,31 bn | 5,31 bn | 5,30 bn | 6,16 bn | 6,27 bn | 5,37 bn | 5,25 bn |
| EPS | 3,38 | 3,43 | 2,15 | 1,92 | 3,35 | 3,00 | 2,00 | 1,90 | 3,18 | 3,50 | 1,97 | 1,40 |
| Margin | 12,0% | 12,4% | 9,4% | 8,5% | 13,1% | 12,0% | 9,5% | 9,1% | 13,1% | 14,2% | 9,4% | 6,8% |
| FCF | 976 m | 1,24 bn | 800 000 | 862 m | 1,11 bn | 931 m | −250 m | 635 m | 839 m | 952 m | −343 m | 599 m |
From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.
Owners
Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.
Insider trades over 12 months
Over 12 months: no purchases, sales $12,7 m.
| Name | Amount | Shares | Price |
|---|---|---|---|
| lang james p.4 Nov 2026 · sale | $249 280 | 689 | $361,80 |
| lang james p.4 Nov 2026 · sale | $224 459 | 620 | $362,03 |
| young bryan j3 Nov 2026 · sale | $454 263 | 1 314 | $345,71 |
| jaye james r3 Nov 2026 · sale | $795 134 | 2 301 | $345,56 |
| garceau mary l2 Nov 2026 · sale | $1,36 m | 3 891 | $350,42 |
| binns justin t17 Aug 2026 · sale | $4,76 m | 13 500 | $352,70 |
| jorgenrud karl j7 Aug 2026 · sale | $2,90 m | 7 886 | $368,30 |
| young bryan j24 Feb 2026 · sale | $915 913 | 2 513 | $364,47 |
| davie colin m.2 Feb 2026 · sale | $1,07 m | 2 976 | $359,50 |
SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.
About the company
- Industry
- Chemicals
- Exchange
- NYSE
- Country
- US
- IPO date
- 11 Feb 1964
- Website
- www.sherwin-williams.com
Company description, revenue by segment and region, and the CEO will come later.
Earnings
- Next report
- date not announced
An AI summary of the earnings call will come later.
Peers
| Company | Price | ||||
|---|---|---|---|---|---|
ECLEcolab | $308,41 | 72★★★★★★★★★would consider | 41,6 | +9,3% | 12,1% |
APDAir Products | $313,90 | 38★★★★★★★would not consider | 132,5 | +4,5% | −0,4% |
LINLinde plc | $523,46 | 72★★★★★★★★★would consider | 34,5 | +8,2% | 19,3% |
PPGPPG Industries | $121,97 | 100★★★★★★★★★★would consider | 17,2 | +18,2% | 9,4% |
DOWDow Inc. | $31,96 | no score | — | — | — |
Ratio — a score by our methodology, not an investment recommendation.




